Skip to content

Retrospective Analysis of Veritas in Breast Reconstruction

Retrospective Analysis of Veritas in Breast Reconstruction (RAVE)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01454713
Acronym
RAVE
Enrollment
54
Registered
2011-10-19
Start date
2010-10-31
Completion date
2011-10-31
Last updated
2017-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection, Necrosis, Seroma

Brief summary

Retrospective data collection of the use of Veritas in breast reconstruction surgery

Detailed description

This is a multi-center study to retrospectively collect data on the use of Veritas Collagen Matrix in breast reconstruction. Data will be collected on post-operative complications in immediate breast reconstruction and then be compared to literature reported post-operative complication rates associated with the use of acellular dermal matrix in immediate breast reconstruction.

Interventions

None listed

Sponsors

Synovis Surgical Innovations
CollaboratorINDUSTRY
Baxter Healthcare Corporation
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Patients who underwent mastectomy with immediate breast reconstruction using Veritas collagen matrix * Patients who underwent mastectomy with single stage procedures or two-stage procedures using Veritas collagen matrix

Exclusion criteria

* Patients who underwent delayed breast reconstruction * Reconstruction with something other than Veritas collagen matrix * Breasts that were created with DIEP or TRAM procedures

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026